Daily State of the Markets Good morning. Make no mistake about it; Monday’s stock market was all about debt. There was the talk of possible debt restructuring in Greece (which would mean at least one sovereign debt default), rising rates at Spain’s T-Bill auction, another hike in the reserve requirement in China, a downgrade of Ireland’s banks, talk of the EU’s bailout program hitting snags, and most importantly, and S&P’s downgrade of the outlook rating on debt right here in the good ‘ol USofA. While no one really expects the U.S. to default, the downgrade of S&P’s rating outlook from “stable” to “negative” could prove to be a game changer for the market. Remember, this game is about confidence. And if confidence starts to droop or uncertainty creeps into the mix, well, all those Wall Street analysts looking for big gains in the stock market this year might begin to rethink their view. While the bears did their level best to scare the bajeebers out anyone holding long positions on Monday morning, things didn’t really turn out all that bad. Sure, the Dow was down 250 points at one point. But instead of collapsing and/or snapping what appeared to be fragile support zones, the bulls managed to get their act together in the afternoon. Thus, instead of a scary decline that in and of itself could have been a game changer on a chart basis, Monday’s mayhem may turn out to be just another test of support at the 1300 level. The bulls argue that there are exactly two chances that U.S. debt could actually be downgraded: slim and none. Our heroes in horns point to the action in the bond market, which actually saw yields fall as the day progressed, as well as the VIX, which failed to perk up on the purported game-changing event. Those looking at the bright side also suggest that S&P’s move may wind up being a good thing if it can get a politician or two riled up enough to actually get something done about the debt and the budget. However, on the other side of the court, the bears could be heard telling anyone willing to listen yesterday afternoon that this thing (i.e. the corrective phase the market finds itself stuck in) isn’t over. Our furry friends point out that the austerity kick, which seems to be all the rage in Europe these days, is sure to catch on here. The only problem is that less spending means less economic growth, which, in turn, could easily mean lower profits for corporate America. Now toss in the President’s plan to hike taxes on anybody making a little money and it isn’t hard to see how stocks could encounter a problem from a big-picture perspective later in the year. But for now, the fact that stocks didn’t collapse on Monday tells us that traders want to see some more earnings before throwing in the towel. So, with Goldman Sachs, Johnson & Johnson, CSX, Intel, IBM, and Yahoo all reporting today and a steady stream of results continuing for the next couple weeks, we’re still of the mind that if there is going to be a game changer in the near-term, it will likely come from the collective guidance and corporate commentaries from the earnings parade. So stay tuned and keep your ears to the ground. Turning to this morning… While Asian markets followed the U.S. lower, European markets are rebounding on the back of solid PMI reports. The mood in the U.S. is also improved based on earnings from the likes of Goldman Sachs. On the Economic front… Housing Starts rose by 7.2%% in March to an annualized rate of 549K. This was above the consensus for 519K. Building Permits for March rose 11.2% to 594K. This was also above the consensus of 537K and last month’s reading of 534K. Thought for the day: Resist the temptation to tell people only what they want to hear… Pre-Game Indicators Here are the Pre-Market indicators we review each morning before the opening bell…
Wall Street Research Summary Upgrades: |
Robbins & Myers (RBN) – BMO Capital Domtar (UFS) – Citi raises estimates and target Mead Johnson (MJN) – Credit Suisse U.S. Steel (X) – Removed from short-term sell list at Deutsche Bank SL Green Realty (SLG) – Added to short-term buy list at Deutsche Bank Zions Bancorp (ZION) – FBR Capital Navistar (NAV) JPMorgan Eaton (ETN) – Oppenheimer Mattel (MAT) – Piper Jaffray Goodrich (GR) – Wedbush
Downgrades:
SuccessFactors (SFSF) – JMP Securities Bio-Rad Laboratories (BIO) – Leerink Swan Lifepoint Hospitals (LPNT) – Morgan Stanley Cabot Oil & Gas (COG) – Stifel Nicolaus Excel Trust (EXL) – UBS
Long positions in stocks mentioned: FTI
For more “top stock” portfolios and research, visit TopStockPortfolios.com
The opinions and forecasts expressed herein are those of Mr. David Moenning and may not actually come to pass. Mr. Moenning’s opinions and viewpoints regarding the future of the markets should not be construed as recommendations. The analysis and information in this report and on our website is for informational purposes only. No part of the material presented in this report or on our websites is intended as an investment recommendation or investment advice. Neither the information nor any opinion expressed nor any Portfolio constitutes a solicitation to purchase or sell securities or any investment program. The opinions and forecasts expressed are those of the editors of TopStockPortfolios and may not actually come to pass. The opinions and viewpoints regarding the future of the markets should not be construed as recommendations of any specific security nor specific investment advice. Stocks should always consult an investment professional before making any investment.
Any investment decisions must in all cases be made by the reader or by his or her investment adviser. Do NOT ever purchase any security without doing sufficient research. There is no guarantee that the investment objectives outlined will actually come to pass. All opinions expressed herein are subject to change without notice. Neither the editor, employees, nor any of their affiliates shall have any liability for any loss sustained by anyone who has relied on the information provided.
The analysis provided is based on both technical and fundamental research and is provided “as is” without warranty of any kind, either expressed or implied. Although the information contained is derived from sources which are believed to be reliable, they cannot be guaranteed.
The information contained in this report is provided by Ridge Publishing Co. Inc. (Ridge). One of the principals of Ridge, Mr. David Moenning, is also President and majority shareholder of Heritage Capital Management, Inc. (HCM) a Chicago-based money management firm. HCM is registered with the U.S. Securities and Exchange Commission as an investment adviser. HCM also serves as a sub-advisor to other investment advisory firms. Ridge is a publisher and has not registered as an investment adviser. Neither HCM nor Ridge is registered as a broker-dealer.
Employees and affiliates of HCM and Ridge may at times have positions in the securities referred to and may make purchases or sales of these securities while publications are in circulation. Editors will indicate whether they or HCM has a position in stocks or other securities mentioned in any publication. The disclosures will be accurate as of the time of publication and may change thereafter without notice.
Investments in equities carry an inherent element of risk including the potential for significant loss of principal. Past performance is not an indication of future results.